US Pharma MarketingSchrödinger and BMS expand partnership to deploy AI for drug discovery
Schrödinger and BMS expand partnership to deploy AI for drug discovery is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Schrödinger has entered a strategic agreement with BMS to integrate its AI-based co-scientist platform Bunsen into BMS’s research operations.
Source: Pharmaceutical Technology